• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征女性雄激素的卵巢和肾上腺来源评估。地塞米松和促性腺激素释放激素激动剂的应用。

Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration.

作者信息

Fulghesu A M, Lanzone A, Fortini A, Guido M, Caruso A, Mancuso S

机构信息

Department of Obstetrics and Gynecology, Universitá Cattolica del Sacro Cuore, Rome, Italy.

出版信息

J Reprod Med. 1993 May;38(5):387-92.

PMID:8320677
Abstract

Ovarian and adrenal production of androgens was evaluated in 18 patients with polycystic ovary syndrome (PCOS) by administering a combination of short-term dexamethasone (DEX) and long-term gonadotropin-releasing hormone agonist (GnRH-A). At day 6 of the cycle, blood samples were collected at 7 A.M. (basal) and 11 P.M. At midnight, 2 mg DEX was given orally, and blood samples were collected at 7 A.M. the following day (DEX1). Blood samples were obtained for 6 weeks at the same time after administration of a potent GnRH-A (400 micrograms/day given subcutaneously). Eight normal subjects served as controls. The amounts of androgens and 17-hydroxyprogesterone (17-OHP) suppressed by using DEX (adrenal-source suppression) and GnRH-A (ovarian-source suppression) were greater in PCOS patients than in controls. We differentiated PCOS patients as having a normal or an exaggerated response to DEX or GnRH-A administration; threshold values were considered average +2SD of the suppressed androgen amounts of controls. Three patients had an exaggerated response to GnRH-A treatment for androstenedione, testosterone and 17-OHP, while DEX inhibition was similar to controls. The remaining 15 patients had an exaggerated response to DEX for all three androgens; seven also had an exaggerated response to GnRH-A. Thus, the combination of GnRH-A and DEX permitted us to selectively study and identify adrenal and ovarian sources of hyperandrogenemia.

摘要

通过联合使用短期地塞米松(DEX)和长期促性腺激素释放激素激动剂(GnRH - A),对18例多囊卵巢综合征(PCOS)患者的卵巢和肾上腺雄激素生成情况进行了评估。在月经周期的第6天,于上午7点(基础值)和晚上11点采集血样。午夜口服2毫克地塞米松,并于次日上午7点采集血样(DEX1)。在给予强效GnRH - A(皮下注射400微克/天)后,连续6周在同一时间采集血样。8名正常受试者作为对照。PCOS患者中,使用DEX(肾上腺来源抑制)和GnRH - A(卵巢来源抑制)所抑制的雄激素和17 - 羟孕酮(17 - OHP)量高于对照组。我们将PCOS患者分为对地塞米松或GnRH - A给药反应正常或过度的类型;阈值被认为是对照组抑制雄激素量的平均值 + 2标准差。3例患者对GnRH - A治疗的雄烯二酮、睾酮和17 - OHP反应过度,而地塞米松抑制作用与对照组相似。其余15例患者对所有三种雄激素的地塞米松抑制反应过度;其中7例对GnRH - A的反应也过度。因此,GnRH - A和地塞米松的联合使用使我们能够选择性地研究和确定高雄激素血症的肾上腺和卵巢来源。

相似文献

1
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration.多囊卵巢综合征女性雄激素的卵巢和肾上腺来源评估。地塞米松和促性腺激素释放激素激动剂的应用。
J Reprod Med. 1993 May;38(5):387-92.
2
Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.慢性促性腺激素释放激动剂给药后多囊卵巢疾病的口服避孕药治疗。持续卵巢抑制的预测因素。
J Reprod Med. 1996 Sep;41(9):645-52.
3
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.17-羟孕酮对促性腺激素释放激素的反应揭示了功能性卵巢高雄激素血症和多囊卵巢综合征的不同表型。
J Clin Endocrinol Metab. 2007 Nov;92(11):4208-17. doi: 10.1210/jc.2007-0870. Epub 2007 Sep 4.
4
Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.多囊卵巢综合征女性中卵巢17-羟孕酮对促性腺激素释放激素(GnRH)激动剂激发试验的高反应性并非由促黄体生成素分泌过多介导:来自GnRH激动剂和人绒毛膜促性腺激素刺激试验的证据
J Clin Endocrinol Metab. 1996 Nov;81(11):4103-7. doi: 10.1210/jcem.81.11.8923867.
5
[Androgen response in women with polycystic ovary syndrome and hyperinsulinemia during stimulation with corticotrophin and inhibition with dexamethasone].[多囊卵巢综合征和高胰岛素血症女性在促肾上腺皮质激素刺激和地塞米松抑制过程中的雄激素反应]
Rev Invest Clin. 1996 Jul-Aug;48(4):267-73.
6
Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome.
Obstet Gynecol. 1995 Jun;85(6):971-6. doi: 10.1016/0029-7844(95)00065-Y.
7
Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome.卵巢和肾上腺在多囊卵巢综合征患者高雄激素血症中的作用。
Exp Clin Endocrinol Diabetes. 2005 Feb;113(2):115-21. doi: 10.1055/s-2004-830540.
8
17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.多囊卵巢综合征患者中17-羟孕酮对促性腺激素释放激素激动剂布舍瑞林和促肾上腺皮质激素的反应:肾上腺和卵巢细胞色素P450c17α失调的研究
Hum Reprod. 1997 May;12(5):910-3. doi: 10.1093/humrep/12.5.910.
9
Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.高胰岛素血症增强了多囊卵巢综合征妇女中 GnRH 激动剂刺激的卵巢甾体激素分泌。
J Clin Endocrinol Metab. 2012 May;97(5):1712-9. doi: 10.1210/jc.2011-2939. Epub 2012 Mar 14.
10
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.吡格列酮可降低多囊卵巢综合征高胰岛素血症女性对促肾上腺皮质激素释放因子的肾上腺雄激素反应,而促肾上腺皮质激素释放不受影响。
Fertil Steril. 2007 Jul;88(1):131-8. doi: 10.1016/j.fertnstert.2006.11.076. Epub 2007 Mar 6.